Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccine
Chaitanya Kurhade, Wei J. Chen, Weiqiang Li…·Kayvon Modjarrad
This study evaluates the immunogenicity of an LP.8.1-adapted BNT162b2 vaccine against JN.1 sublineages, showing higher neutralizing antibody responses compared to other adapted vaccines.